YSB

YSB Financial Leverage

The Financial Leverage (Equity Multiplier) of YSB (9885.HK) as of Oct 20, 2026 is 3.10. In the previous year, Financial Leverage (Equity Multiplier) was 2.80 — a change of 10.51% (higher).

Financial Leverage

3.10

YoY

10.51%

Last updated:

Financial Leverage (Equity Multiplier) of YSB is 2025 3.10 . Financial Leverage (Equity Multiplier) of YSB was 2024 2.80 . It decreases by 10.51% higher compared to the previous year.

The YSB Financial Leverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Financial Leverage
Date
Financial Leverage
Jan 1, 2020
-1.05 CNY
Jan 1, 2021
-1.18 CNY
Jan 1, 2022
-0.94 CNY
Jan 1, 2023
2.71 CNY
Jan 1, 2024
2.80 CNY
Jan 1, 2025
3.10 CNY
The YSB Financial Leverage history
YEARFinancial LeverageYoY
3.10+10.51%
2.80+3.16%
2.71-387.48%
-0.94-20.28%
-1.18+12.59%
-1.05—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

YSB Stock analysis

What does YSB do? YSB, Inc. generates revenue through the wholesale and retail of pharmaceuticals and healthcare products via offline and online platforms. The company operates an online platform enabling pharmaceutical distributors to sell their products, while also offering software-as-a-service (SaaS) solutions to pharmacies. Additionally, YSB sells smart unmanned pharmaceutical booths to third-party pharmacies and provides maintenance and technical support services for these booths. The firm's primary market is domestic, serving pharmacies, distributors, and primary medical institutions through its SaaS and testing services. The company's SaaS solutions target pharmacies, helping them manage operations, while the smart unmanned pharmaceutical booths are sold to third-party pharmacies for retail distribution. Medical testing services are provided directly to primary medical institutions, and the firm's online platform connects distributors with buyers. All services and products are focused on the domestic market, with no international operations mentioned in the description. YSB, Inc. makes money by selling pharmaceuticals and healthcare products through its platforms, offering SaaS to pharmacies, and providing maintenance services for smart booths. The firm's revenue streams include direct sales of products, SaaS subscriptions, booth sales, and technical support contracts. Primary customers are pharmacies, distributors, and primary medical institutions, all operating within China's domestic market. YSB is one of the most popular companies on Eulerpool.

Frequently Asked Questions about YSB stock

Financial Leverage (Equity Multiplier) of YSB is 3.10 in 2025.

Financial Leverage (Equity Multiplier) of YSB changed from 2.80 to 3.10, representing a 10.51% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Financial Leverage (Equity Multiplier) YSB since 2006 – with annual values, charts, and detailed analysis.

Financial leverage, also known as the equity multiplier, measures total assets relative to equity. Higher leverage amplifies both returns and risks.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Financial Leverage (Equity Multiplier)'s YSB with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — YSB

All Key Metrics — YSB